Penn Medicine reports $118M gain as revenues approach $5B

Philadelphia-based Penn Medicine has reported $118 million in net income for the six months ending Dec. 31 as revenues increased to almost $5 billion.

Advertisement

The figures compare with net income of $280.3 million in the same period in 2021 as investment values declined and expenses rose in 2022. Operating income for the 2022 period totaled $103.6 million versus $152.5 million in 2021.

Long-term debt at the eight-hospital system — which includes one of the largest facilities in the country, the Hospital of the University of Pennsylvania  in Philadelphia — totaled almost $2.5 billion as of Dec. 31.

The system called off its alliance with West Reading, Pa.-based Tower Health earlier in February.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.